Fingolimod effective in all subgroups: analysis of phase III data

December 18, 2012

Recommend to a Colleague print

 

REPORT FROM THE 25^TH CONGRESS OF THE EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS) – AMSTERDAM, THE NETHERLANDS, OCTOBER 19-22, 2011 –

Subscribe to read more

It takes 30 seconds
or login using your email address

Please enter the email address that you registered the newsletter with
Continue

Recommend to a Colleague

Related Posts

• New AAN guidelines for migraine prophylaxis
  July 11, 2012
• Breastfeeding not a sustainable therapy
  July 11, 2012
• Exploratory study of higher carbidopa dosing
  July 11, 2012
• Emerging MS therapies: update on injectable drugs
  November 30, 2011
• CONFIRM – Second phase III trial results for BG-12
  November 30, 2011

Go back to home page